Tainan, Taiwan

Chien-Hsin Pan

This inventor holds 1 USPTO granted patent. Top assignee: Colossus Biopharma Consultants Company, Limited. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chien-Hsin Pan: Innovator in Fluorescent Imaging Technologies

Introduction

Chien-Hsin Pan is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of biomedical imaging, particularly through his innovative work on fluorescent compounds. His research focuses on enhancing the imaging of blood vessels and blood flow, which has important implications for medical diagnostics and treatment.

Latest Patents

Chien-Hsin Pan holds a patent for "Fluorescent compounds for imaging of blood vessels and blood flow, and an in vivo screen for pro- and anti-angiogenic agents." This invention discloses fluorescent compounds and a method for their use in selective imaging of blood vessels and blood flow. By applying these fluorescent compounds and the imaging process to a zebrafish model, the invention provides methods and procedures for the discovery, selection, and characterization of pro- and anti-angiogenic agents. He has 1 patent to his name.

Career Highlights

Chien-Hsin Pan is associated with Colossus Biopharma Consultants Company, Limited, where he continues to advance his research and development efforts. His work is pivotal in the field of biopharmaceuticals, particularly in the area of imaging technologies that can lead to better understanding and treatment of vascular diseases.

Collaborations

Chien-Hsin Pan collaborates with talented individuals in his field, including Yen-Shi Lai and Yu-Ting Lo. These collaborations enhance the research output and innovation potential within his projects.

Conclusion

Chien-Hsin Pan is a distinguished inventor whose work in fluorescent imaging technologies is paving the way for advancements in medical diagnostics. His contributions are vital for the future of biopharmaceutical research and development.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…